Browsing by Author "Lloreta Trull, Josep, 1958-"

Sort by: Order: Results:

  • López De Maturana, Evangelina; Picornell, Antoni; Masson-Lecomte, Alexandra; Kogevinas, Manolis; Márquez, Mirari; Carrato, Alfredo; Tardón, Adonina; Lloreta Trull, Josep, 1958-; García Closas, Montserrat; Silverman, Debra T.; Rothman, Nathaniel; Chanock, Stephen J.; Real, Francisco X.; Goddard, M. E.; Malats i Riera, Núria; SBC/EPICURO Study Investigators (BioMed Central, 2016)
    BACKGROUND: We adapted Bayesian statistical learning strategies to the prognosis field to investigate if genome-wide common SNP improve the prediction ability of clinico-pathological prognosticators and applied it to ...
  • Martin-Cardona, Albert; Lloreta Trull, Josep, 1958-; Albero-González, Raquel; Paraira Beser, Marta; Andújar Murcia, Xavier; Ruiz-Ramirez, Pablo; Tur-Martínez, Jaume; Ferrer, Carme; Marcos Izquierdo, José Angel de; Pérez-Madrigal, Anna; Goiburú González, Laura; Espinós Perez, Jorge; Esteve, Maria (BioMed Central, 2021)
    Background: SARS-CoV-2 may produce intestinal symptoms that are generally mild, with a small percentage of patients developing more severe symptoms. The involvement of SARS-CoV-2 in the physiopathology of bowel damage is ...
  • Hernández Llodrà, Sílvia; Segalés Tañà, Laura, 1994-; Juanpere, Nuria; Lorenzo, Marta; Salido Galeote, Marta; Nonell Mazelón, Lara; López, David; Rodríguez-Vida, Alejo; Bellmunt Molins, Joaquim, 1959-; Fumadó Ciutat, Lluis; Cecchini Rosell, Lluís; Lloreta Trull, Josep, 1958- (Wiley, 2021)
    Background: In the non-ETS fusion of prostate cancer (PCa) pathway, SPOP mutations emerge as a distinct oncogenic driver subclass. Both SPOP downregulation and mutation can lead to SPOP target stabilization promoting ...
  • Bowden, Michaela; Nadal, Rosa; Zhou, Chensheng W.; Werner, Lillian; Barletta, Justine A.; Juanpere, Nuria; Lloreta Trull, Josep, 1958-; Hernández Llodrà, Sílvia; Morote, Juan; Torres, Inés de; Orsola, Anna; Cejas, Paloma; Long, Henry; Bellmunt Molins, Joaquim, 1959- (Nature Research, 2020)
    No consensus currently exist on the optimal treatment of patients with high-risk nonmuscle invasive (HGT1) micropapillary variant of bladder cancer (MPBC). Transcripsome analysis may allow stratification of MPBC-HGT1 ...